Acadian Asset Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-21,566
Closed -$248K 2082
2024
Q3
$248K Buy
21,566
+13,056
+153% +$149K ﹤0.01% 1292
2024
Q2
$89K Buy
8,510
+1,603
+23% +$17.6K ﹤0.01% 1548
2024
Q1
$72K Buy
+6,907
New +$74.5K ﹤0.01% 1338

Other funds holding ROIV

Acadian Asset Management's ROIV Position: Q4 2024 in Review

Acadian Asset Management sold out of Roivant Sciences (ROIV) in Q4 2024, closing a stake of 21,566 shares — an estimated $248K sold.

Acadian Asset Management first reported a position in ROIV in Q1 2024 and held it in 3 quarters. The position peaked at $248K in Q3 2024. 318 funds tracked by Wall St. Rank hold ROIV as of Q4 2024.

  • Acadian Asset Management reported no remaining Roivant Sciences position as of Q4 2024 after selling out during the quarter.
  • Acadian Asset Management sold 21,566 Roivant Sciences shares in Q4 2024, an estimated $248K.
  • Acadian Asset Management first reported a position in Roivant Sciences in Q1 2024 and held it in 3 quarters.
  • Acadian Asset Management's Roivant Sciences position peaked at $248K in Q3 2024.
  • 318 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.